Although patients with diabetes contract infectious diseases at higher frequencies, and in more severe forms, compared to non-diabetics, the underlying defects of the immune function have not been defined clearly. 
Introduction
Type 2 diabetes mellitus (T2DM) is a chronic disease with a high prevalence worldwide. The disease was previously considered simply to be a metabolic disorder and unrelated to the immune system. However, recent studies clearly suggest that T2DM is linked intimately with the immune system, both causally and consequently. Elevated level of the circulatory proinflammatory cytokine tumour necrosis factor (TNF)-α induces the development of insulin resistance in various tissue cells [1] . Moreover, infections are a common cause of morbidity and mortality in patients with diabetes, which suggests that decreased host immunity to infections develops in patients with diabetes. Bacterial and fungal infections of the respiratory and urinary tract surrounding these findings, and whether the whole immune system is affected by diabetes has not yet been addressed fully.
The comprehensive measurement of the immune capacity of an individual is a daunting task [11] . The human immune system is composed of complex networks with diverse cells and molecules [12, 13] . Changing a single immune component could lead to phenotypical alteration in multiple immune processes. Alternatively, there may not be any phenotypical change, owing to the redundancy of the components. Therefore, when we explore the underlying mechanism for a single immune phenotype, for example the increased susceptibility to infection, multiple immune components need to be evaluated simultaneously. In this study, we designed an immune monitoring protocol that measures the salient immune functions of various immune cells. By comparing the measures obtained from T2DM patients and normal healthy people using this protocol, we addressed whether there are any functional changes in the immune system in T2DM. Our data show that there is no significant functional alteration in the innate immune cells and T lymphocytes of T2DM patients.
Materials and methods

Study design, subjects and sample preparation
A total of 33 patients with T2DM were recruited at the National Medical Center (Seoul, Korea). Inclusion criteria were diabetes duration of more than 5 years and age between 50 and 70 years. Exclusion criteria included patients with stages 3 and 4 chronic kidney disease, macrovascular complication, malignancy, infection history in the past 6 months or current immunosuppressive treatment. Clinical data were obtained from medical files. A total of 35 healthy volunteers fulfilling the inclusion and exclusion criteria except for the presence of diabetes were also included into this study. A total of 10 ml of peripheral blood from individual participants was collected in heparin tubes. In a few participants, two to four repeat blood samplings were performed during the period of a year to check the reproducibility of the measures. Peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation using Ficoll-Paque solution (GE Healthcare, Chicago, IL, USA) and stored in liquid nitrogen. At the same time, plasma was collected and used as an autologous culture supplement. The experimental scheme to measure the functional immune status of individuals is illustrated in Fig. 1 . The study was approved by the Ethics Committee of National Medical Center, and written informed consent was obtained from all participants.
Stimulation culture of PBMCs
Frozen PBMCs were thawed and rested overnight in RPMI-1640 medium containing 10% fetal bovine serum (FBS). After resting, the cells were cultured in RPMI-1640 medium supplemented with 2 mM glutamine, 1% (v/v) non-essential amino acids, 1% (v/v) sodium pyruvate, 1% (v/v) HEPES, penicillin (50 U/ml), streptomycin (50 µg/ml) [medium and culture supplements from Invitrogen (Carlsbad, CA, USA)] and 10% (v/v) heatinactivated (56°C, 30 min) autologous plasma. To evaluate innate immune responses, PBMCs (4 × 10 5 cells/well) were 
Cytokine assay
The concentration of inflammatory cytokines present in culture supernatants was measured using Bio-Plex Multiplex Immunoassays (Bio-Rad Laboratories, Hercules, CA, USA), according to the manufacturer's instructions.
Flow cytometry
The composition of immune cell subsets in PBMCs and the extent of DC maturation were analysed by immunofluorescent staining of cell surface markers using the following antibody cocktails: surface I: CD3 FITC (clone SK7), CD4 peridinin chlorophyll-cyanin 5.5 (PerCP-Cy5.5) (RPA-T4), CD8 allophycocyanin (APC)-H7 (SK1), CD45RA PC7 (2H4), CCR7 phycoerythrin (PE) (G043H7), CD57 
Statistical analysis
Statistical analysis was performed using Prism version 5.04 software (GraphPad, San Diego, CA, USA). The nonparametric Mann-Whitney U-test was used to compare two groups. A non-linear regression curve fit was applied to calculate the half maximal effective concentration (EC 50 ) of LPS inducing the half-maximal response of TNF-α secretion. Differences were considered statistically significant at P < 0·05.
Results
Characteristics of the study population
A total of 33 patients with T2DM and 35 healthy controls were enrolled into this study ( 
Blood cell composition
The proportion of various immune cell subsets in PBMCs was examined by immunophenotyping, adopting the recommended cell surface markers [14] . CD3 + T cells were distinguished by the expression of CD4 and CD8, together with CCR7 and CD45RA (Fig. 2 ). For each of the CD4 + and CD8 + T cells, naive, central memory, effector memory and effector cells were defined as CCR7 + CD45RA + , CCR7 + CD45RA -, CCR7 -CD45RA + and CCR7 -CD45RA -, respectively. We also determined the functional exhaustion and senescence of T cells by investigating the expression of PD-1 and CD57, respectively. B cells were defined as CD3 -CD19 + cells, and they were divided further into naive and memory cells by the expression of CD27 (Fig. 2) . Among the CD3 -CD19 -cells, monocytes, NK cells and myeloid DCs were defined as CD14 + , CD14 -CD56 + and CD14 -CD56 -CD11c + cells, respectively. T2DM patients had similar frequencies of T cells, including both CD4 + and CD8 + T cell subsets, NK cells, monocytes and myeloid DCs compared with healthy control individuals (Fig. 2) . The percentage of total B cells and naive B subsets was higher in T2DM than in the normal population (8·08 ± 3·44% versus 6·63 ± 2·68%; 74·45 ± 9·18% versus 67·8 ± 10·19%, mean ± s.d.), while the opposite was true of the memory B cell subset (25·55 ± 9·18% versus 32·2 ± 10·19%) ( Fig. 2) . Among the four CD4 + and CD8 + T cell subpopulations, the proportion of effector cells was higher in T2DM than the control group (2·85 ± 1·48% versus 2·16 ± 1·06%; 43·33 ± 14·16% versus 36·01 ± 13·64%), whereas the other three subpopulations did not show a difference (Fig. 2e ). There was no difference in the proportion of exhausted and senescent T cells between T2DM and the healthy control group (Fig. 2f ). The composition of PBMCs did not change in each individual during the period of a year ( Fig. 2c and data not shown).
Proinflammatory cytokine production of leucocytes
One of the major defence mechanisms of the innate immune system against microbial infection is the production of proinflammatory cytokines to eliminate the invading pathogens. We examined if this function is intact or not in patients with T2DM. When PBMCs were stimulated with different doses of LPS, a representative pathogen-associated molecular pattern (PAMP), the LPS dose-response of TNF-α secretion was not statistically different between the T2DM and normal control groups (Fig. 3a) . Similarly, the LPS concentration inducing half-maximal response of TNF-α secretion and the amount of TNF-α secreted at the half-maximal response were not different between the two groups (4.24 ± 1.52 versus 4.57 ± 0.93 ng/ml; 9586 ± 9310 versus 7975 ± 5916 pg/ml, mean ± s.d.). IL-1β secretion of PBMCs from T2DM patients also did not differ from that of control individuals (Fig. 3b) . Notably, it was revealed that spontaneous secretion of TNF-α and IL-1β from unstimulated PBMCs was not different between the two groups (data not shown). In addition to proinflammatory cytokines, an anti-inflammatory cytokine (IL-10) secretion was not significantly different between the two groups upon stimulation with LPS. The cytokine secretion of PBMCs tended to be preserved across different time-points of blood sampling from the same subjects ( Fig. 3c ).
Phenotypical maturation of DCs
DCs are important cells that link the innate and adaptive immune systems. When DCs are activated by the engagement of their receptors with PAMPs, they efficiently and productively present peptide antigens to T lymphocytes by enhancing the expression of co-stimulatory and major histocompatibility complex (MHC) molecules on their cell surfaces. Thus, we analysed the extent of up-regulation of HLA-DR, CD40 and CD86 expression on DCs after the stimulation of PBMCs with different doses of LPS and compared these values between T2DM and control groups. In this experiment, we focused on myeloid DCs (mDCs), the major antigen-presenting cells, by gating of HLA-DR + CD11c + cells among lineage negative cells (CD3 -CD14 -CD19 -) (Fig. 4) . The up-regulation of HLA-DR and CD40 expression was more enhanced in mDCs from T2DM patients compared with those from control subjects at mid-and high-dose LPS stimulation, while CD86 did not differ significantly (Fig. 4) . These data suggest that the antigen-presenting ability of mDCs to T lymphocytes is not compromised, but slightly enhanced in T2DM patients compared to that in normal people. 
Functional activity of NK cells
A major function of NK cells is to kill directly or indirectly and remove virus-infected and cancer cells. To perform this function, NK cells must specifically recognize the target cells. Unfortunately, however, the entire spectrum of specific receptors and pathways for this process has not yet been discovered. We devised a simple protocol to measure the general functionality of NK cells. After initial priming with pIC, which mimics viral infection, and subsequent challenge with anti-CD16/anti-NKG2D, which simulates the engagement of two major activating NK cell receptors, cytolytic activity and IFN-γ secretion were measured by determining the externalization of CD107a in NK cells and intracellular cytokine staining, respectively (Fig. 5a ). These measures of NK cell function did not change significantly within the same person throughout a period of a year (Fig. 5b) . When we analysed the cytolytic and IFN-γ secretion function of NK cells using the above assay protocol, we found that both the frequency of functioning NK cells and the magnitude of their functional activity, determined by mean fluorescence intensity (MFI) of CD107a and IFN-γ staining in functioning NK cells, was not different between T2DM and control groups (Fig.  5c,d ), indicating that NK cell function is intact in T2DM. 
Functional differentiation status of CD4 + T cells
When CD4 + T cells encounter their cognitive antigens, they differentiate into various types of T helper (Th) cells to mount an optimal immune response. We examined whether there is a skewed distribution of functional helper T cell subtypes in T2DM patients. PBMCs were stimulated with anti-CD3 and anti-CD28 microbeads and determined the proportion of specific helper T cell subtypes by intracellular prototype-cytokine staining (Fig 6a) . We first confirmed the stability of our measurements in samples taken from the same person at different time-points throughout the year (Fig 6b) . We then compared the proportions of specific helper T cell subtypes between T2DM and control groups, and found that there was no significant difference in the proportion of Th1, Th2, Th17 and Tr1 subtypes present (Fig. 6c) .
Functional activity of CD8 + T cells
Next, we examined two main functional activities, cytolytic activity and cytokine secretion, of CD8 + T cells by measuring the externalization of CD107a and intracellular cytokine staining after stimulation of PBMCs with anti-CD3 and anti-CD28 (Fig. 7) . The frequency and magnitude of the functional activity of cytolytic CD8 + T cells were not significantly different between T2DM and normal control groups (Fig. 7) . Moreover, IFN-γ and IL-4 secretion in CD8 + T cells did not differ between the two groups (Fig. 7) . These data showed that neither CD4 + nor CD8 + T cell functions were affected in T2DM patients.
Discussion
Evaluation of the comprehensive functional immune status of an individual can provide critical information needed to prevent the contraction of disease and to maintain health. Unfortunately, an effective and standard protocol is not currently available for this evaluation. Whether there is any defect in immune function in T2DM patients is unclear, although several fragmented and inconsistent studies have been reported previously [6] [7] [8] [9] [10] . In this study, by applying a simple protocol designed to measure the prototypical function of various immune cells using a minimal volume of blood, we investigated the impact of long-lasting T2DM on the human immune system. As the functional outcome of immune response derives from the complex interactions among various cells and molecules in a specific person, we tried to keep all the immune constituents of an individual the same in our assay process, except for the external stimuli. That is, whole PBMCs were always used in stimulation cultures even when we measured the function of a specific cell type. Moreover, autologous plasma was added as culture supplement. Therefore, the functional activity of specific immune cells measured in our protocol could be regarded as the product influenced by the other immune components. When evaluated by this protocol, we revealed that patients with longlasting T2DM do not have a major defect in innate and cellular immune responses. The capacity for inflammatory cytokine production in patients with diabetes has been investigated in several previous studies [15] [16] [17] [18] [19] [20] [21] , although there is still no consensus on this issue. In the case of LPS stimulation, heterogeneous results have been reported ranging from increased to decreased and even unchanged production of proinflammatory cytokines [15] [16] [17] [18] [19] [20] . Most studies have measured the quantity of cytokines produced from PBMCs or monocytes in response to a single dose of LPS. By contrast, we used various doses of LPS to determine the dose that induced the half-maximal response of cytokine production, together with the amount of cytokine detected at this point. From these measures, we obtained detailed information on both the sensitivity and magnitude of immune cells to secrete proinflammatory cytokines in response to LPS stimulation. By comparing these critical data obtained from T2DM and the healthy control group, we concluded that the proinflammatory cytokine production capacity of PBMCs was not impaired significantly in T2DM. However, it should be noted that small functional changes were difficult to detect by this approach, because relatively large personal variation exists in those measures, even in the normal control group.
NK cells are known to contribute to the development of T2DM by secreting inflammatory factors, especially in association with obesity [22] . However, there is little information on whether NK cell function can be altered by long-lasting T2DM. Berrou et al. [8] reported that NK cells from patients with diabetes had a significantly decreased NKG2D expression and degranulation ability compared to those from healthy donors, while this impairment could be reversed by supplementation with IL-15. Another study also reported the diminished cytotoxic activity of NK cells in T2DM patients [23] . In contrast to these previous reports, our data demonstrated clearly that cytolytic and cytokinesecreting abilities of NK cells are well preserved in T2DM patients. These discrepant results might come from the different assay protocols used to measure NK cell function. Previous studies used K562 cells to induce cytolytic activity of NK cells, whereas our study employed pIC pretreatment and the cross-linking of specific activating receptors (NKG2D and CD16). Our assay system is set up to reflect the circumstances of a viral infection in physiological conditions. Nonetheless, further studies will be required to reach a consensus on this issue. DCs play a pivotal role in the initiation of the cellular immune response [24] . The efficient presentation of antigens to T cells requires the activation of DCs, which is manifested by the up-regulation of MHC and co-stimulatory molecule expression on the cell surface. PAMPs and inflammatory cytokines are representative inducers for DC activation [25] . The impairment of DC maturation leads to the reduction of the host's ability to combat microbial infection. A previous study, in which in-vitrogenerated monocyte-derived DCs (MDDC) were examined, revealed comparable expression of HLA-DR and CD86 on mature MDDC derived from type 2 patients with diabetes and healthy controls [26] . The conserved activation state and maturation capacity were also reported to be detected in blood DCs of type 2 patients with diabetes, although poor production of IFN-α by the enriched DC population was also found [27] . As the main producer of IFN-α is the pDC subset [28] , the latter finding must derive from a functional defect in pDCs rather than in mDCs. Our findings that the up-regulation of HLA-DR and co-stimulatory molecules on endogenous blood mDCs in response to LPS stimulation was not impaired, but slightly enhanced in patients with diabetes compared to control subjects, also supports the functional maintenance of mDCs in T2DM. Therefore, it could be concluded that mDC function is intact in T2DM, at least in its ability to present antigens to T cells. CD4 + T cells play a pivotal role in modulating immune responses. Different subsets of CD4 + T cells display distinct immune functions primarily by secreting different cytokines [29] . Th1 cells have the capacity to produce IFN-γ as a prototype cytokine and to engage in protective immunity against viral infection and cancer. Th2 cells play an important role in augmenting B cell responses by secreting IL-4 and IL-13. Th17 cells are characterized by their ability to produce IL-17 and play a critical role in defence against It has been suggested that a disturbed CD4 + T cell subset balance is associated with several disease categories, such as autoimmune diseases, cancers and chronic inflammatory diseases [30] [31] [32] [33] . In T2DM patients, we found that there was no difference in the composition of CD4 + T cell subsets compared to the normal control group. However, there are several previous reports suggesting that Th1 and Th17 frequencies are elevated in blood of people with T2DM compared to control subjects [17, 34, 35] . In addition to the use of different stimulants to induce cytokine production from CD4 + T cells, some mismatches in demographic characteristics between patients and control groups in those studies might produce a result discordant from ours. Moreover, as an increase of Th1 and Th17 frequency is associated with the extent of patient obesity [17] , it might not be detected in our study population of T2DM, which did not include many obese patients. Although the decrease of regulatory CD4 + T cell (T reg ) frequency in T2DM patients has also been reported previously [35] , we examined IL-10-producing T reg -1 cells, but not forkhead box protein 3 (FoxP3) + T regs in our study.
The main functional activity of CD8 + T cells is cytotoxicity of virus-infected and cancer cells. Modulation of other immune cell functions by secreting cytokines is another functional activity of CD8 + T cells. We addressed the occurrence of any functional changes in CD8 + T cells in T2DM patients. The higher frequency of effector CD8 + T cells observed in T2DM patients compared to control subjects at basal state suggests that ongoing CD8 + T cell response is higher in T2DM. However, our functional analysis revealed that the cytotoxic and cytokine-producing activity of CD8 + T cells in response to anti-CD3 stimulation was not altered in T2DM. Consistent with our results, the results of previous studies also demonstrated that the frequency of CD8 + T cell subsets (Tc1, Tc2 and Tc17) secreting prototypical cytokines or expressing CD107a was not altered in T2DM when stimulated with a polyclonal activator. However, in response to specific microbial antigens, the functional activity of CD8 + T cells of T2DM patients has been reported to be heterogenous, depending on infection and disease status [36] [37] [38] . Thus, more sophisticated analyses should be applied to clarify the exact impact of T2DM on CD8 + T cell function.
B cells are another important immune cell population which mediate the humoral immune response. Our phenotypical analysis demonstrated a slight increase in B cell proportion, especially naive B cells, in peripheral blood. Previous studies have shown that B lymphocytes from patients with diabetes were less apoptotic [39] and less proliferative to mitogen stimulation [40] than were control B lymphocytes. Thus, these alterations in B cell survival and division might be related to the changes in B cell proportion in diabetes patients. Although we have not examined B cell function in this study, it has been reported previously that antibody response to vaccines is not impaired in T2DM patients [9] . Collectively, from the screening of fundamental immune functions, no evidence for profound alteration in the cellular compartment of the immune system could be found in patients with long-lasting T2DM. It could be argued that relatively healthy T2DM patients were included in our study population by excluding the patients with stages 3 and 4 chronic kidney disease, cancer or recent infection history, which could affect the outcome of our study. Although this might be the case, we wanted to exclude the possibility that those medical conditions themselves have an impact on the immune system. It should be also noted that not all the cell components involved in immune responses have been screened in our study. Polymorphonuclear cells also play an important role in defence against bacterial infections, and the functional deterioration of these cells has been shown to be raised in T2DM patients [6] . Moreover, impaired barrier functions due to peripheral neuropathies and frequent medical procedures often occur in patients with long-lasting T2DM. All these factors might contribute to the increased susceptibility to infections in patients with diabetes.
Although we believe that our screening protocol used in this study can easily assess the general capacity of cell functions, it does not provide the information for the functional capacity of cells in association with the specificity of stimuli, which is a hallmark of the immune response. The wide range of measures in our study population is another obstacle in analysing the data obtained from our immune screening protocol. The significance and underlying mechanisms of natural variation of immune responses among healthy people are being explored actively [41] . To establish the best strategy to cope with the increased susceptibility to infection in patients with diabetes, thorough understanding of their immune status by using improved immune monitoring protocols will be needed.
In conclusion, by using an immune screening protocol to measure the fundamental functions of circulating immune cells, we found that the basic functional activities of monocytes, mDCs, NK cells and T lymphocytes were not altered in long-lasting T2DM patients. This finding could help to prepare appropriate management strategies for T2DM patients.
